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Abstract
Clinical Description: KBG syndrome is characterized by macrodontia of upper central incisors, distinctive
craniofacial features such as triangular face, prominent nasal bridge, thin upper lip and synophrys; skeletal findings
including short stature, delayed bone age, and costovertebral anomalies; and developmental delay/intellectual
disability sometimes associated with seizures and EEG abnormalities. The condition was named KBG syndrome
after the initials of the last names of three original families reported in 1975.
Epidemiology: The prevalence of KBG syndrome is not established. There are over 100 patients reported in the
literature. It is likely that KBG syndrome is underreported due to incomplete recognition and very mild
presentations of the disorder in some individuals. KBG syndrome is typically milder in females.
Etiology: Causative variants in ANKRD11 have been identified in affected individuals. The vast majority of identified
variants are loss of function, which include nonsense and frameshift variants and larger deletions at 16q24.3.
Haploinsufficiency appears to be the mechanism of pathogenicity.
Genetic Counseling: Familial and de novo cases have been reported. Causative de novo variants occur approximately
one third of the time. Transmission follows an autosomal dominant pattern. The syndrome displays inter- and
intra-familial variability.
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KBG syndrome- key points summary
 KBG syndrome is a rare, pan ethnic, autosomal
dominant disorder, typically with more severe
findings in males
 Clinical presentation is characterized by
macrodontia, distinctive craniofacial findings,
skeletal findings, post-natal short stature, and
developmental delays [1]
 Point mutations, indels, and large deletions in
ANKRD11 account for most but not in all cases [2–4]
 While there are no formal diagnostic criteria, several
have been proposed. A clinical diagnosis of KBG
syndrome should be suspected in an individual with
two or more of the findings highlighted by an
asterisk OR one finding highlighted by an asterisk
with at least two more findings: [1–3, 5]
▪ *Macrodontia of permanent upper central incisors
▪ *Developmental delay or mild/moderate intellectual
disability or learning difficulty associated with
behavioral issues
▪ *Characteristic facial appearance
▪ *Post-natal short stature
▪ *1st degree relative with KBG syndrome
▪ Conductive hearing loss due to recurrent otitis
media
▪ Palatal abnormalities
▪ Hair findings (eg. low hair line, coarse hair)
▪ Delayed bone age (>2SD below mean)
▪ Large anterior fontanelle with delayed closure
▪ Hand findings
▪ Costovertebral anomalies
▪ Scoliosis
▪ EEG abnormalities with or without seizures
▪ Feeding difficulties
▪ Cryptorchidism in males
 Individuals with 16q24.3 deletion involving the
ANKRD11 gene have similar findings to those with
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intragenic variants, but also have a higher incidence
of other findings such as brain anomalies, congenital
heart defects, severe astigmatism, thrombocytopenia,
and potentially autism spectrum disorder among
other behavioral problems [2, 6–8]
 Missense ANKRD11 variants should be interpreted
with caution as the vast majority of reported
variants have been loss of function
Background
KBG syndrome (Orpha 2332; MIM 148050) was first
described in 1975 by Herrmann et al. [9] as a new
“malformation/retardation syndrome” in three families.
Developmental delays, short stature, dysmorphic features,
and macrodontia were common findings among these
families. The condition was named KBG syndrome after
the initials of the last names of three original families [9].
While originally described as an autosomal dominant
condition, subsequent reports showed that males were
much more severely affected than females; hence for
many years X-linked inheritance remained a possibility.
Subsequent families supported autosomal dominant in-
heritance, which was confirmed by demonstration of
causative ANKRD11 variants in affected individuals [4].
It remains still unknown why females are less severely
affected.
Epidemiology
There have been over 100 cases of KBG syndrome re-
ported [2, 3]. KBG syndrome was initially thought to be
quite rare, however is likely underdiagnosed due to mild
features [4]. Features are typically present at birth but
may be difficult to recognize until developmental delays
are apparent, or permanent teeth erupt. Also, it is likely
that this syndrome is less frequently diagnosed since fea-
tures are not severe and fairly common among other
disorders [4]. The syndrome is pan-ethnic.
Clinical findings and natural history
Following summary shows typical findings of KBG
syndrome:
Craniofacial findings (60–80% of reported individuals):
Triangular face, brachycephaly, synophrys and hyper-
telorism. A prominent high nasal bridge, anteverted
nostrils, long philtrum, and thin upper lip are also com-
mon [2, 10] (Fig. 1).
Dental findings (85% of reported individuals): Macro-
dontia, especially of the permanent maxillary central
incisors, is a main finding and is present in most but not
all affected individuals [11]. This is typically defined as
greater than or equal to 10 mm in males and 9.7 mm in
females [1, 4]. Cleft teeth, shovel shaped incisors, enamel
hypoplasia, oligodontia, dental pits and supernumerary
mamelons (rounded protuberances present on the cutting
edge of an incisor tooth) can also be seen [11] (Fig. 2).
Skeletal findings (75% of reported individuals): Skeletal
anomalies are common and variable among affected
individuals. Most frequent are costovertebral anomalies
[1]. Short stature (below −1 SD) is also seen in over half
of patients with KBG syndrome [2]. Delayed bone age is
an additional finding [5]. A large anterior fontanelle with
delayed closure can also be seen [3]. Other abnormalities
may include abnormal ribs, brachydactyly, clinodactyly,
kyphosis, scoliosis, hip dysplasia, sternum abnormalities,
and Wormian bones in skull [10]. (Fig. 3).
Neurological findings
Intellectual abilities in childhood (93% of reported indi-
viduals have had developmental delays): Cognitive skills
can be quite variable among individuals. Most patients will
have some degree of developmental delay, especially in
speech [12]. There have not been any reports of regres-
sion. Average age for walking was 21 months [3, 10]. Aver-
age age for first words was 36 months [10]. Some children
attend mainstream classes while others require special
education [3].
Fig. 1 Craniofacial findings of KBG syndrome. (a, b, c) The same patient when he was 6 and 11 years old; (d) a 48-year-old patient. Note triangular
face, synophrys, downslanting palpebral fissures, ptosis, high nasal bridge, anteverted nostrils, long philtrum, thin upper lip, and low anterior hairline
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Intellectual abilities in adulthood: It is not uncommon
for verbal IQ to surpass performance IQ. Disability levels
can range from mild learning disabilities, especially in
females, to moderate intellectual disability, especially in
males [12]. Completing a regular high school without
additional support appears to be rare; however some re-
ported adults have completed a trade school. More than
half had jobs and were self-sufficient [2, 3].
Seizures (up to 50% of reported individuals): EEG ab-
normalities, with or without seizures have been reported
in patients. Age of onset can be from infancy to the teens
[3]. The type of epilepsy is nonspecific, although tonic-
clonic seizures are most common. Treatment with antiep-
ileptic drugs has proven to be effective in the majority of
cases. Many patients have remission of symptoms after
adolescence [12].
Brain malformations: Some brain abnormalities have
been reported, although these are variable and are not in-
cluded as part of the suggested diagnostic criteria. These
abnormalities include cerebellar vermis hypoplasia [13],
Fig. 2 Macrodontia of permanent upper central incisors (a, b) Typical appearance of central upper incisors; (c) Prominent mamelons; (d) Slightly
increased width of upper central incisors
Fig. 3 Skeletal findings. (a) Accessory ribs; (b) Spina bifida occulta; (c, d):Clinodactyly
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enlarged cysterna magna, Chiari I malformation, menin-
gomyelocele [10, 14], and periventricular nodular hetero-
topia [15]. The frequency of brain anomalies has not been
established in big cohorts.
Psychiatric (50–70% of reported individuals): Behav-
ioral issues are common among patients with KBG syn-
drome although they can be variable. Milder problems
can include poor concentration and restless movement.
More severe problems can include obsessions, and deteri-
orating behavior when routines are changed. Anxiety and
shyness are not uncommon, as are reports of difficulty in
understanding social situations. [3]. While behavior issues
are common among these individuals, autism spectrum
disorder has been reported in varying frequencies suggest-
ing ascertainment bias [2].
Hearing (25–31% of reported individuals have had
hearing loss): Recurrent otitis media has been shown to
cause hearing loss in some patients with KBG. All types
of hearing loss, conductive, mixed and sensorineural,
have been reported in association with the disease, with
conductive loss to be the most common. Other otolaryn-
golic issues, such as soft cleft palate, bifid uvula, and
velopharyngeal insufficiency have been reported [2, 10].
Gastrointestinal findings: Feeding difficulties, gastro-
esophageal reflux disease, and constipation have all been
reported among patients with KBG syndrome [3].
Other findings: Undescended testicles have been re-
ported in 25–35% of males [10]. Various ocular findings
have been reported with KBG syndrome. While they
are not common they include strabismus, congenital
bilateral cataract, high myopia, and megalocornea [10].
Advanced puberty, some requiring treatment, has been
reported in some individuals. Cardiac defects have been
reported in approximately 10–26% of individuals, in-
cluding atrial septal defects (ASD) and ventricular sep-
tal defects (VSD) among others [2]. Hypertrichosis has
also been reported [3].
Diagnosis of KBG syndrome
A clinical diagnosis of KBG syndrome should be sus-
pected in an individual with two or more of the findings
highlighted by an asterisk OR one finding highlighted by
an asterisk with at least two more findings: [1–3, 5]
▪ *Macrodontia of permanent upper central incisors
▪ *Developmental delay or mild/moderate intellectual
disability or learning difficulty associated with
behavioral issues
▪ *Characteristic facial appearance
▪ *Post-natal short stature
▪ *1st degree relative with KBG syndrome
▪ Conductive hearing loss due to recurrent otitis media
▪ Palatal abnormalities
▪ Hair findings (eg. low hairline, coarse hair)
▪ Delayed bone age (>2SD below mean)
▪ Large anterior fontanelle with delayed closure
▪ Hand findings
▪ Costovertebral anomalies
▪ Scoliosis
▪ EEG abnormalities with or without seizures
▪ Feeding difficulties
▪ Cryptorchidism in males
A pathogenic or likely pathogenic DNA variant involv-
ing the ANKRD11 gene confirms the diagnosis. Absence
of an ANKRD11 mutation does not exclude the diagnosis
of KBG syndrome.
Etiology
Single nucleotide variants and small indels within
ANKRD11 account for approximately 83% of pathogenic
variants and larger copy number variants (mostly dele-
tions) involving ANKRD11 detectable by chromosomal
microarray account for approximately 17% [2, 3].
There are currently no definitive genotype-phenotype
correlations. Preliminary evidence suggests that individ-
uals with a microdeletion involving only ANKRD11
tend to have less neurological involvement than intra-
genic mutation carriers [16]. Individuals with a larger
deletion, encompassing ANKRD11 and other sur-
rounding genes appear to have increased risk of neu-
robehavioral abnormalities [2, 6–8, 16]. It has also
been seen that individuals with microdeletions have a
higher incidence of congenital heart defects, astigma-
tism, and thrombocytopenia than those with intragenic
mutations [16].
The syndrome is thought to be fully penetrant with vari-
able expressivity. Males tend to be more severely affected
than females for unknown reasons [4]. Intra-familial vari-
ability is commonly reported [3].
Differential diagnosis
While many features are present from birth, it may be
difficult to diagnose due to the mild or vague features that
overlap with other syndromes [17]. Mild Cornelia de
Lange syndrome (CdLS) has many similar findings
including the facial features, developmental delay, growth
retardation, hearing loss, and cryptorchidism. However,
individuals with CdLS tend to have smaller head circum-
ference and greater degrees of intellectual disability [18].
Russell Silver syndrome (RSS) also has overlap with KBG
syndrome, exhibiting similar facial features, developmental
delay, growth retardation, and cryptorchidism. However,
individuals with RSS typically have prenatal onset growth
retardation and limb asymmetry [19]. Aarskog syndrome
has similar features to KBG syndrome including short
stature, facial features, macrodontia, brachydactyly,
vertebral anomalies, and cryptorchidism. However these
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individuals typically have a normal IQ and a characteristic
shawl scrotum [20].
ANKRD11 molecular characterization
Intragenic variants and microdeletions including
ANKRD11 have been reported to result in KBG
syndrome [4, 8]. Seventy-nine of the 86 previously re-
ported ANKRD11 variants in patients with KBG syn-
drome are truncating and the majority of these cluster
to the ninth exon (NM_013275.5), with only a handful
of recurrent mutations being reported to date (Fig. 4,
Additional file 1: Table S1). Only four missense
ANKRD11 variants have been reported to cause KBG
syndrome (Fig. 4, Additional file 1: Table S1). However,
phenotype was either mild or absent in some heterozy-
gotes with missense variants; missense variants should
be interpreted with caution. Confirming causality of
rare missense variants requires multiple unrelated af-
fected individuals with the same variant or co-
segregation of variants with the phenotype in familial
cases. A de novo missense variant in a person with high
clinical suspicion supports the diagnosis. The preva-
lence of truncating variants points towards haploinsuffi-
ciency as the underlying cause of disease [2, 4]. This
mechanism is supported by reports of microdeletion
resulting in the complete loss of the coding region of
ANKRD11 [2]. However, a dominant-negative mechanism
of action may be superseding haploinsufficiency in pa-
tients who carry a variant that leaves the N-terminus of
the protein intact [21].
ANKRD11 is located on the long arm of chromosome 16
and encodes for the protein Ankyrin repeat domain-
containing protein 11. ANKRD11 contains four domains:
an ankyrin repeat domain, a transcription activation
domain, and two transcription repressions domains [22, 23]
(Fig.4). Previous reports show that ANKRD11 primarily lo-
calizes to the nucleus [21]. ANKRD11 interacts directly
with tumor suppressor protein TP53, and has been
shown to fluctuate in abundance during the progression
of the cell cycle [21, 22]. It also acts as a co-regulator.
ANKRD11 interacts with p160 coactivators and several
HDAC corepressors, which results in the inhibition of
ligand-dependent transcriptional activation [23, 24].
More recently, ANKRD11 has been shown to regulate
neural development by directing histone acetylation
and gene expression [25].
Mouse model
The mouse ortholog Ankrd11 has a 79% identity at the
amino acid level with human ANKRD11. A chemically
induced (N-ethyl-N-nitrosourea; ENU) mutagenesis
screen generated the Ankrd11Yod/+ allele, a missense
mutation at a highly conserved residue (E2502K) [26].
The Ankrd11Yod/+ or Yoda mouse was reported before
the identification of ANKRD11 mutations in KBG syn-
drome. The Yoda mice present with craniofacial anomal-
ies that include deformed nasal bones, shortened snouts,
and wider skulls and are similar to the craniofacial
anomalies seen in KBG syndrome. The Yoda mice also
exhibit neuroanatomical perturbations such as neurons
misplaced around the lateral ventricles [25] and behav-
ioral abnormalities that are similar to those observed in
humans with KBG syndrome [25].
Clinical management
There are no formal management guidelines published
for KBG syndrome. After initial diagnosis, the following
have been suggested:
Fig. 4 Location of reported causative variants in ANKRD11. Asterisks show location of recurrent variants, and y-axis gives reference for number of
occurrences. From left to right these recurrent variants are as follows: NM_013275.5:c.1381_1384del (p.Glu461Glnfs*48), NM_013275.5:c.1801C > T
(p.Arg601*), NM_013275.5:c.1903_1907del (p.Lys635Glnfs*26), NM_013275.5:c.2398_2401del (p.Glu800Asnfs*62), NM_013275.5:c.2408_2412del
(p.Lys803Argfs*5), and NM_013275.5:c.3224_3227del (p.Glu1075Glyfs*242). The length of each line is proportional to the number of occurrences.
ANK: Ankyrin repeat-containing domain (p.152–304). RD1: Repression Domain1 (p.318–611). Activation Domain (p.1851–2145). RD2: Repression
Domain2 (p.2369–2663). Boundaries of exons are shown as alternating black and white boxes
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 Cardiology: referral to cardiology for echocardiogram
 Otolaryngology: palatal assessment and regular
hearing tests
○ if otitis media is recurrent, ENT should consider
placement of tympanostomy tubes
 Ophthalmology: evaluation for myopia, strabismus,
and other ocular abnormalities
 Dentistry: evaluation for macrodontia, oligodontia
and enamel hypoplasia [11]
 Neurology: evaluate for abnormal EEG or seizures
○ seizures typically respond to treatment with
medication [12]
 Endocrinology: emerging evidence suggests that
growth hormone may be successful in treating short
stature. Referral to endocrinology if pubertal
problems are present [27]
 Urology: evaluate for undescended testicles
 Nutrition: dieticians should be consulted if feeding
issues are present [2, 3]
 Therapies: for developmental delay and behavior
problems. Interventions at school if learning
disabilities are present.
Prognosis
Cognitive: KBG syndrome can be quite variable in
regard to the cognitive abilities of affected individuals.
There have been no reports of regression. Most chil-
dren will require support within the classroom, some
requiring special education. [3, 12]. Completing a
regular high school without additional support ap-
pears to be rare; however some reported adults have
completed a trade school. More than half had jobs
and were self-sufficient [2, 3]. Some were able to live
completely independently, while others required some
assistance with tasks at home, such as finances. Some
affected women have had children and raised them
with additional help from a spouse or other family
members [2, 3] .
Seizures: Many patients have remission of symptoms
after adolescence [12].
Growth: Short stature is common although emerging
evidence suggests that growth hormone may be success-
ful in treating short stature [27].
Conclusions
KBG syndrome is a rare genetic disorder characterized by
macrodontia of upper permanent incisors, distinctive cra-
niofacial features, skeletal findings, and developmental
delay/intellectual disability with behavioral abnormalities.
Awareness of the syndrome will facilitate its clinical diag-
nosis, which should be confirmed by detecting ANKRD11
variants. Alternatively, a gene panel or whole exome/gen-
ome study would yield a causative ANKRD11 variant,
especially in young children or patients with an atypical
presentation. Further studies will help delineating the
spectrum of phenotype, details of ANKRD11 function and
dysfunction in KBG syndrome, and missing variants either
in ANKRD11 or in additional genes in patients with a cli-
nical diagnosis of KBG syndrome.
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